October 2011 Issue of MMM
While trawling through the MM&M archives ahead of our this, our 45th birthday, I found hundreds of gems—each story helping to chronicle the magnitude, direction ...
Aided by the digital revolution, patient marketing programs get increasingly personal, with more customization aimed at differentiating products and keeping patients on therapy, Matthew Arnold ...
"Patient-centric" may be the buzz, but who's really inspiring better health choices? Alyson Connor shares findings from the behaviorists at MicroMass Communications
The comeback continues. Professional journal advertising climbed in first-half 2011, driven by new and mature products. Marc Iskowitz on the biggest advertisers and most advertised ...
Mark Iwicki's top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia.
Targeted therapies have opened doors to tumor control. As drugmakers aim for more focused patient groups, realistic expectations on pricing and revenue potential are proving ...
How pharmaceutical marketing research could benefit from understanding behavioral economics.
Over 80% of hospitals report that shortages of lifeseaving drugs are delaying patient care
Oral anticoagulant Eliquis (apixaban) has demonstrated superior efficacy and bleeding profile to standard warfarin therapy. Barring any bombshells, that should be enough for this agent, ...
LEO Pharma, Inc., a wholly owned US subsidiary of the 100-year old Danish organization LEO Pharma A/S, has reported growth of 85% in the overall ...
Pfizer's Lipitor website touted the efficacy of Caduet, Chantix and Norvasc but the site failed to balance those claims by providing any risk information for ...
Featuring news about Enzo Life Sciences, Manhattan Research, Concentric Pharma Advertising and TargetRx
Med Ed Report
ProPublica juiced up its doc payment search, but left out context, industry critics charge.
State-accredited CME providers continue to decrease, but so far the trend has not posed a threat to physician education, one official says.
Featuring news on ProPublica, American Academy of Physician Assistants, Peach New Media, Dartmouth College Press and the ACCME
Most doctors rated colleagues as their most important source of new medical developments.
Medical Economics, a journal publication of Advanstar Communication's medical division, has reported ad revenue growth of 49.6% in the first six months of 2011 over ...
inVentiv Health agency GSW Worldwide has launched a KOL Whitepaper called UP:ROOT, to be produced twice yearly. It will observe trends in healthcare and pharma ...
Featuring news about Dove Medical Press, Monthly Prescribing Reference and Unbound Medicine
Everyday Health hired an ABC News exec to head up its health video and global news efforts.
Google Inc. has agreed to a $500 million payout to the US government, following a Department of Justice (DOJ) investigation.
Featuring news about Novo Nordisk, Quantia MD/Care Continuum Alliance and the Parkinson's Disease Fondation
Sanofi US has teamed up with crooner Barry Manilow in kicking off a national awareness campaign for atrial fibrillation (AFib) called "Get Back in Rhythm."
Viagra's new DTC campaign is an engaging piece of advertising that refreshes the brand.
AT&T names Geeta Nayyar, MD its first-ever chief medical information officer.
Average marketing research salaries in 2011 are up, according to MM&M's 25th Annual Career & Salary Survey.
ImpactRx, which measures the impact of promotion on prescriber behavior, said it acquired 100% of TargetRx, a pharma sales and marketing effectiveness firm.
Healthcare marketing agency inVentiv Health has further extended its breadth of services to the European market with the launch of a new shop called inVentiv ...
The Centers for Medicare and Medicaid Services (CMS) awarded Fleishman-Hillard, Ketchum, Ogilvy PR Worldwide, Porter Novelli and Weber Shandwick open-ended PR contracts for up to ...
Featuring news about Sudler & Hennessey, Singularity Design and Edelman
As companies prepare to report payments under the Physician Payment Sunshine Act, there are significant concerns.
Sen. Charles Grassley (R-IA) is criticizing Office of Management and Budget (OMB) officials for weakening an HHS transparency rule on disclosure of financial ties between ...
The Pharmaceutical Re-search and Manufacturers of America is defending industry patent set-tlements after an August 31 FTC report on authorized generics.
Individual brands may be sluggish at leveraging the power of branded or unbranded channels, but on the corporate level they're tuning in. Here are a ...
Name That Brand
More than enough has been written how change is affecting our industry today. Instead, let's look at what hasn't changed and why the things that ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.